0.00Open3.70Pre Close0 Volume0 Open Interest85.00Strike Price0.00Turnover1733.86%IV-3.11%PremiumDec 6, 2024Expiry Date6.16Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9826Delta0.0134Gamma21.31Leverage Ratio-30.3301Theta0.0000Rho-20.94Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet